Jove
Visualize
Contact Us

Related Experiment Videos

A new small-molecule Stat3 inhibitor.

John S McMurray1

  • 1Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 36, Houston, Texas 77030, USA.

Chemistry & Biology
|November 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease.

The Journal of biological chemistry·2018
Same author

Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer.

International journal of radiation oncology, biology, physics·2018
Same author

Mutational Profiles Reveal an Aberrant TGF-β-CEA Regulated Pathway in Colon Adenomas.

PloS one·2016
Same author

Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma.

Oncotarget·2015
Same author

Long-Acting Beta Agonists Enhance Allergic Airway Disease.

PloS one·2015
Same author

Targeting the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 6 (STAT6) with Cell-Permeable, Phosphatase-Stable Phosphopeptide Mimics Potently Inhibits Tyr641 Phosphorylation and Transcriptional Activity.

Journal of medicinal chemistry·2015
Same journal

The Hedgehog Pathway Effector Smoothened Exhibits Signaling Competency in the Absence of Ciliary Accumulation.

Chemistry & biology·2017
Same journal

DIVERSE System: De Novo Creation of Peptide Tags for Non-enzymatic Covalent Labeling by In Vitro Evolution for Protein Imaging Inside Living Cells.

Chemistry & biology·2015
Same journal

Differential Regulation of Specific Sphingolipids in Colon Cancer Cells during Staurosporine-Induced Apoptosis.

Chemistry & biology·2015
Same journal

Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase Iα.

Chemistry & biology·2015
Same journal

Unraveling the B. pseudomallei Heptokinase WcbL: From Structure to Drug Discovery.

Chemistry & biology·2015
Same journal

Vitamin C as Cancer Destroyer, Investigating Sulfhydration, and the Variability in CFTR Interactome.

Chemistry & biology·2015
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Researchers discovered Stattic, a small molecule that blocks the SH2 domain of Signal Transducer and Activator of Transcription 3 (Stat3). This finding provides a new tool for studying Stat3 signaling pathways.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Chemical Biology

Background:

  • Signal Transducer and Activator of Transcription 3 (Stat3) is a critical transcription factor involved in various cellular processes, including proliferation, survival, and immune responses.
  • The SH2 domain of Stat3 plays a crucial role in mediating protein-protein interactions by recognizing phosphotyrosine-containing motifs.

Discussion:

  • This study introduces Stattic, a novel small molecule inhibitor.
  • Stattic specifically targets and inhibits the interaction between phosphopeptides and the SH2 domain of Stat3.
  • This inhibition demonstrates that the Stat3 SH2 domain is a druggable target.

Key Insights:

  • Discovery of Stattic, a potent inhibitor of Stat3 SH2 domain phosphopeptide binding.
  • Validation of the SH2 domain as a viable target for therapeutic intervention in Stat3-mediated pathways.

Related Experiment Videos

  • Provides a new chemical tool for dissecting Stat3 signaling.

    • Outlook:

    • Stattic offers a valuable research tool for further investigation of Stat3 functions in normal and disease states.
    • Potential for developing new therapeutic strategies targeting Stat3 signaling in cancer and inflammatory diseases.
    • Further studies are warranted to explore the full potential and applications of Stattic in biological research and drug discovery.